A phase II study of mitoxantrone in squamous cell carcinoma of head and neck origin was conducted. Fiftythree evaluable patients were treated with this agent at a dosage of 5 mg/M2/week. The majority of patients were of high performance status. Twenty-seven patients had received previous chemotherap
β¦ LIBER β¦
A phase II study of primary reirradiation in squamous cell carcinoma of head and neck
β Scribed by Johannes A. Langendijk; Nicolien Kasperts; Charles R. Leemans; Patricia Doornaert; Ben J. Slotman
- Book ID
- 118496626
- Publisher
- Elsevier Science
- Year
- 2006
- Tongue
- English
- Weight
- 109 KB
- Volume
- 78
- Category
- Article
- ISSN
- 0167-8140
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Phase II study of mitoxantrone in advanc
β
Stephen D. Williams; Robert Birch; Enrique Velez-Garcia; Richard Gams
π
Article
π
1985
π
Springer US
π
English
β 170 KB
Phase II study of doxifluridine in advan
β
Abele, Reto; Kaplan, Eli; Grossenbacher, Rudolf; Schmid, Hans J.; Cavalli, Franc
π
Article
π
1984
π
Elsevier Science
β 305 KB
727 poster A prospective study on postop
π
Article
π
2004
π
Elsevier Science
π
English
β 254 KB
A phase II study of adriamycin in previo
β
Melody A. Cobleigh; James H. Hill; Patricia A. Gallagher; Lawrence J. Kukla; Tho
π
Article
π
1985
π
John Wiley and Sons
π
English
β 278 KB
π 2 views
Twenty patients with squamous cell carcinoma of the head and neck (SCC H/N) were treated with Adriamycin (doxorubicin) at a dosage of 60 mg/m\* at 3-week intervals. No patient had received surgery, radiation, or chemotherapy before treatment with Adriamycin. Responses were observed in 44% of 18 eval
1023 POSTER Phase II study of capecitabi
π
Article
π
2005
π
Elsevier Science
π
English
β 137 KB
A phase II study of pirarubicin in patie
β
P. H. M. De Mulder, P. Cappelaere, F. Cognettiβ¦
π
Article
π
1994
π
Springer
π
English
β 296 KB